Skip to content
Biorelate logo — The most advanced data curation in biopharma. Galactic AI™ i...

Biorelate

The most advanced data curation in biopharma. Galactic AI™ is powered by the best of LLM, AI and NLP technology.

Founded 2014 United Kingdom Manchester, United Kingdom 38 employees Series A Total: $7.30M Big Data, Biotechnology +2

General Information

Company Name Biorelate
Founded Year 2014
Location United Kingdom Manchester, United Kingdom
Employees 38
Industries Big Data, Biotechnology, Health Care +1
Funding Stage Series A
Business Model B2B, SaaS, Platform
Revenue Model Subscription, Tiered Pricing, Usage Based
Offices as of Sep 2026
Manchester, United Kingdom
Social

BounceWatch is an independent company data service, not affiliated with Biorelate. To contact Biorelate, visit biorelate.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Biorelate compare?

A PDF of Biorelate and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Biorelate soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Biorelate

Biorelate, founded in 2014 and headquartered in the United Kingdom, is a key player in the intersection of Big Data, Biotechnology, Health Care, and Life Sciences. Their slogan, "The most advanced data curation in biopharma. Galactic AI™ is powered by the best of LLM, AI and NLP technology.", encapsulates their mission to aid scientists in navigating complex biomedical challenges.

The company offers an innovative knowledge graph that significantly enhances capabilities in knowledge review, target and biomarker discovery, understanding mechanisms of action, and expanding indications within biopharma. Their cutting-edge technological approach positions them as a leader in data solutions for the industry.

On 29 November 2022, Biorelate secured a £6.50M Series A investment. The round was backed by notable investors including Triple Point Ventures, Maven Capital Partners, YFM Equity Partners, amongst others, signaling strong confidence in their strategic direction and technological prowess.

Business keywords: Data Curation, Biopharmaceuticals, Knowledge Graph, Biomedical Research, AI Technology, Natural Language Processing, LLM Technology, Target Discovery, Biomarker Discovery, Mechanism of Action, Indication Expansion, Prostate Cancer Diagnosis, Target Validation, Drug Development, Bioinformatics

Services & Products

Galactic AI platform
data curation services
knowledge graph construction
bioinformatics support

Target Customers

pharmaceutical companies biotech firms biologists data scientists information managers

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A £6.50M 5
Triple Point Ventures, Maven Capital Partners +3
01 Nov 2022
Seed £700.00K 3
Catapult Ventures, Maven Capital Partners +1
01 Sep 2018
Seed £100.00K 1
GM&C Life Sciences Fund
01 Mar 2016

Biorelate Alternatives & Competitors

View All Alternatives
Biorelate vs
Elucidata
Elucidata United States

The AI Partner Fueling
40+ FDA-Track Drugs

Series A
167 employees
AI, Analytics
Biorelate vs
Engitix Therapeutics
Engitix Therapeutics United Kingdom

Decoding the ECM space to unlock unprecedented therapies for chronic diseases

Series A
65 employees
Biotechnology, Health Care
Biorelate vs

We are dedicated to building software solutions that transform biomedical data into actionable insig...

Growth
71 employees
Biotechnology, Health Care

FAQ About Biorelate

The most advanced data curation in biopharma. Galactic AI™ is powered by the best of LLM, AI and NLP technology.
Biorelate was founded in 2014.
Biorelate is headquartered in Manchester, United Kingdom.
Biorelate operates in Big Data, Biotechnology, Health Care and Life Sciences. Its work centres on Data Curation, Biopharmaceuticals, Knowledge Graph and Biomedical Research. Its customers include pharmaceutical companies, biotech firms and biologists.
Biorelate has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Tiered Pricing and Usage Based.
Biorelate has approximately 38 employees.
Biorelate has completed 3 funding rounds, raising a total of $7.30M. The latest funding stage is Series A.
Biorelate offers: Galactic AI platform, data curation services, knowledge graph construction, bioinformatics support.
Top alternatives and competitors to Biorelate include Elucidata, Engitix Therapeutics, Molecular Health, MNM Bioscience, ONTOFORCE. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Biorelate and Elucidata are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Biorelate, https://bouncewatch.com/company/biorelate, updated 5 November 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout